Market Signal Briefing

NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating Repare Therapeutics Inc. (NASDAQ: RPTX) related to its sale to XenoTherapeutics, Inc. Upon closing of the proposed transaction, it is estimated that each Repare shareholder will receive a cash payment of $1.82 per share, plus one non-transferable contingent value right entitling the holder to receive certain cash payments under certain conditions. Is it a fair deal?

Click here for more info  https://monteverdelaw.com/case/repare-therapeutics-inc/. It is free and there is no cost or obligation to you.

NOT ALL LAW FIRMS ARE EQUAL. Before you hire a law firm, you should talk to a lawyer and ask:

Do you file class actions and go to Court?When was the last time you recovered money for shareholders?What cases did you recover money in and how much? About Monteverde & Associates PC

Our firm litigates and has recovered money for shareholders…and we do it from our offices in the Empire State Building. We are a national class action securities firm with a successful track record in trial and appellate courts, including the U.S. Supreme Court. 

No one is above the law. If you own common stock in the above listed company and have concerns or wish to obtain additional information free of charge, please visit our website or contact Juan Monteverde, Esq. either via e-mail at [email protected] or by telephone at (212) 971-1341.

Contact:
Juan Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4740
New York, NY 10118
United States of America
[email protected]
Tel: (212) 971-1341

Attorney Advertising. (C) 2025 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com).  Prior results do not guarantee a similar outcome with respect to any future matter.

Artisan and Tulex Report Positive Phase 2a Results for Autism Drug ART-501

November 17, 2025 17:30 ET

 | Source:

Artisan Therapeutics

SAN DIEGO, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Artisan Therapeutics, Inc. (“Artisan”) and Tulex Pharmaceuticals (“Tulex”) today announced encouraging Phase 2a clinical results highlighting the potential of ART-501 for the treatment of autism spectrum disorder (“ASD”)-related conditions. In this pilot, proof-of-concept study, four out of six participants demonstrated meaningful signs of clinical benefit. ART-501 was generally well-tolerated, with adverse events reported as mostly mild and transient, and with no serious adverse events observed.

Behavioral improvements, as measured by the Aberrant Behavior Checklist – Second Edition (ABC-2), were observed in the majority of participants, with notable reductions seen in the ABC-2 subscales for irritability, lethargy/social withdrawal, stereotypic behaviors, and hyperactivity/non-compliance during low-dose ART-501 dosing compared to baseline. The ABC-2 irritability subscale is an established clinical measure that has served as a primary endpoint in FDA-approved therapies for irritability associated with ASD.

The pilot Phase 2a study was a multicenter trial conducted at two U.S. clinical sites that enrolled six adult participants with diagnostically confirmed ASD, five of whom completed treatment. The trial consisted of baseline assessments followed by an open-label period involving low-dose ART-501, then by a blinded, placebo-controlled, crossover period involving higher-dose ART-501.

Dr. Ann Childress, M.D., who was an investigator in the trial, stated, “Autism presents significant challenges for patients and their families, including repetitive behaviors, communication difficulties, and impaired social interactions.” Dr. Childress further commented, “It was very encouraging to see signals of efficacy in several of the participants in the ART-501 study, which supports continued exploration of this use of ART-501 in a larger Phase 2/3 study.”

Dr. Colleen Craig, M.D., Interim Chief Medical Officer (CMO) at Artisan Therapeutics stated, “We are deeply encouraged by the early signs of clinical benefit observed in this Phase 2a study of ART-501. These results highlight the therapeutic potential of our novel extended-release formulation in addressing core symptoms of ASD. At Artisan, our mission is to pursue science-driven innovation for underserved neurodevelopmental conditions, and this milestone represents an important step forward. We look forward to advancing ART-501 into further clinical development in collaboration with Tulex.”

About ART-501

ART-501, formerly known as ARD-501 or TLX-032 for Tulex, is a proprietary oral liquid extended-release formulation of an existing, well-tolerated opioid receptor modulating drug developed through a joint venture between Tulex and Artisan.

About Tulex Pharmaceuticals

Tulex Pharmaceuticals is a U.S. based pharmaceutical company focused on the development of NDA and ANDA products of existing molecules in new dosage forms or new routes of administration. Tulex is a wholly owned subsidiary of Easywell Biomedicals, a publicly listed company in Taiwan (TPEX: 1799.TWO).

About Artisan Therapeutics, Inc.

Artisan Therapeutics, Inc., is a wholly owned subsidiary of Aardvark Therapeutics, Inc. and is focused on the development of ART-501 through a joint venture with Tulex.

Forward-Looking Statements: Certain statements included in this press release that are not historical facts are forward-looking statements. Forward-looking statements are sometimes accompanied by words such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “should,” “would,” “plan,” “predict,” “potential,” “seem,” “seek,” “future,” “outlook” and similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, Tulex’s belief that its unique expertise in developing oral liquid extended-release formulations enables the optimized delivery of an existing opioid receptor modulator offering a promising new approach for the prospective treatment of autism, the therapeutic potential of the novel extended-release formulation in addressing core symptoms of ASD and Artisan’s plans to advance ART-501 into further clinical development in collaboration with Tulex. These statements are based on current expectations and beliefs and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Although we believe that the expectations reflected in our forward-looking statements are reasonable, we do not know whether our expectations will prove correct. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof, even if subsequently made available by us on our website or otherwise. We do not undertake any obligation to update, amend or clarify these forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

Contact:

Carolyn Hawley

[email protected]

Arm on Monday said that central processing units based on its technology will be able to integrate with AI chips using Nvidia's NVLink Fusion technology.

The move will make it easier for customers of both companies who prefer a custom approach to their infrastructure — namely hyperscalers —to pair Arm-based Neoverse CPUs with Nvidia's dominant graphics processing units.

It's the latest example of Nvidia using dealmaking to partner with nearly every major technology company as it finds itself at the center of the AI industry. The announcement signals that Nvidia is opening up its NVLink platform to integrate with a wide variety of custom chips, instead of forcing customers to use its CPUs.

Nvidia currently sells an AI product called Grace Blackwell that pairs multiple GPUs with an Nvidia-branded Arm-based CPU. Other configurations include servers that use CPus from Intel or Advanced Micro Devices.

But Microsoft, Amazon and Google are all developing or deploying Arm-based CPUs in their clouds to give them more control over the set ups and reduce their costs.

Arm doesn't make CPUs but it licenses its instruction set technology that those chips need. The company also sells designs that allow partners to more quickly build Arm-based chips.

As part of Monday's announcement, Arm said that custom Neoverse chips will include a new protocol that'll allow them to move data seamlessly with GPUs.

The CPU has historically been the most important part in a server. But generative AI infrastructure is based around the AI accelerator chip, which in most cases is an Nvidia GPU. As many as eight GPUs can be paird with a CPU in an AI server.

In September, Nvidia said it would invest $5 billion into Intel, the leading CPU maker. A key part of the deal was to enable Intel CPUs to integrate into AI servers using Nvidia's NVLink technology.

Nvidia reached an agreement to buy Arm for $40 billion in 2020, but the deal failed in 2022 because of regulatory issues in the U.S. and U.K. Nvidia had a small stake in Arm, which is majority-owned by Softbank, as of February.

Meanwhile, Softbank liquidated its entire stake in Nvidia earlier this month and Softbank is backing the OpenAI Stargate project, which plans to use Arm technology in addition to chips from Nvidia and AMD.

watch now

Marathon Petroleum (MPC - Free Report) reported $35.85 billion in revenue for the quarter ended September 2025, representing a year-over-year increase of 1.4%. EPS of $3.01 for the same period compares to $1.87 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $30.82 billion, representing a surprise of +16.33%. The company delivered an EPS surprise of -3.22%, with the consensus EPS estimate being $3.11.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Marathon Petroleum performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

Refining & Marketing margin: $17.60 versus the four-analyst average estimate of $17.70.Refining & Marketing margin - Mid-Continent: $19.88 versus the four-analyst average estimate of $18.55.Refining & Marketing margin - West Coast: $19.17 versus $22.38 estimated by four analysts on average.Refining & Marketing - Refinery throughputs - Net refinery throughput: 3005 millions of barrels of oil compared to the 2939.48 millions of barrels of oil average estimate based on four analysts.Refining & Marketing margin - Gulf Coast: $14.77 versus the four-analyst average estimate of $15.03.Refinery throughputs - Mid-Continent - Crude oil refined: 1,147.00 Mbpd compared to the 1,089.39 Mbpd average estimate based on three analysts.Refinery throughputs - West Coast - Gross refinery throughputs: 557.00 Mbpd compared to the 547.29 Mbpd average estimate based on three analysts.Refinery throughputs - West Coast - Other charge and blendstocks: 35.00 Mbpd versus the three-analyst average estimate of 42.24 Mbpd.Refinery throughputs - West Coast - Crude oil refined: 522.00 Mbpd compared to the 505.05 Mbpd average estimate based on three analysts.Refined product yields - Mid-Continent - Total: 1,213.00 Mbpd versus 1,157.28 Mbpd estimated by three analysts on average.Refined product yields - Gulf Coast - Total: 1,330.00 Mbpd compared to the 1,317.00 Mbpd average estimate based on three analysts.Refining & Marketing - Refinery throughputs - Crude oil refined: 2822 millions of barrels of oil versus the three-analyst average estimate of 2729.72 millions of barrels of oil.View all Key Company Metrics for Marathon Petroleum here>>>

Shares of Marathon Petroleum have returned +8.4% over the past month versus the Zacks S&P 500 composite's +1.5% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

MIAMI BEACH, Fla., Nov. 17, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)(“AirSculpt” or the “Company”), a national provider of premium body contouring procedures, today announced the appointment of Mike Doyle as the Non-Executive Chairman of its Board of Directors.

November 17, 2025 5:35 PM EST | Source: ReGen III Corp.
Vancouver, British Columbia--(Newsfile Corp. - November 17, 2025) - ReGen III Corp. (TSXV: GIII) (OTCQB: ISRJF) ("ReGen III" or the "Company"), a leading clean technology company specializing in the upcycling of used motor oil ("UMO") into high-value Group III base oils, is pleased to announce it has received settlement and exchange agreements (the "Sub-Agreements") in the amount of $3.975 million relating to its Convertible Debenture Exchange (the "CD Exchange") announced on November 6, 2025 (Note: Any defined terms used herein have the meanings given to them in the November 6, 2025 news release).

Tony Weatherill, CEO and President of ReGen III, stated, "We have now received Sub-Agreements from over 97% of debenture holders. The nearly 100% agreement to participate in the CD Exchange demonstrates confidence in our strategic direction. With our financial position strengthened, we look forward to accelerating our plans to commercialize sustainable, re-refined Group III base oils."

The Company has made application to the TSX Venture Exchange and expects to close the CD Exchange immediately following the final approval of the TSX Venture Exchange.

The New Debentures and New Warrants have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "U.S. Securities Act"), or any State securities laws, and, accordingly, may not be offered or sold, directly or indirectly, to a U.S. Person except pursuant to an effective registration statement under the U.S. Securities Act (or pursuant to an available exemption from or in a transaction not subject to the registration requirements of the U.S. Securities Act) and in accordance with applicable State securities laws. The Issuer currently has no present intention to and is not obligated to register the New Debentures and New Warrants, and, as a result, this U.S. hold period may be indefinite subject to resale in accordance with Regulation S or other available exemption.

About ReGen III

ReGen III Corp. is driving a new era in high performance, sustainable lubricants. Harnessing its patented ReGen™ technology, the Company is commercializing an advanced process to transform used motor oil ("UMO") into premium Group II and III base oils. These high-quality base oils are essential to high performance engines, turbines, and industrial applications—and ReGen III's process is designed to deliver up to 82% lower CO₂e emissions than virgin crude derived oils combusted at end of life. By turning waste into high-value products, ReGen III is leading the movement toward circular, domestically produced Group III base oils.

With FEL2 and value engineering complete for its proposed 5,600 bpd flagship facility in Texas City, Texas—and backed by worldclass engineering, construction, and vendor partners—the Company is strategically positioned to meet rising demand for higher-quality, circular base oils. In addition to Texas City, the Company is evaluating opportunities to deploy its patented technology across other strategic markets.

With the vision of becoming the world's largest producer of sustainable, re-refined Group III base oils, ReGen III aims to set a new standard for performance and responsibility in the global lubricants market.

For more information on ReGen III or to subscribe to the Company's mailing list, please visit www.regeniii.com.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Certain information other than statements of historical facts contained in this news release constitutes "forward-looking information" or "forward-looking statements" (collectively, "forward-looking information"). Without limiting the foregoing, such forward-looking information includes statements regarding the Company's business plans, expectations, capital costs and objectives. In this news release, words such as "may", "would", "could", "will", "likely", "believe", "expect", "anticipate", "intend", "plan", "estimate" and similar words and the negative form thereof are used to identify forward-looking information. Forward-looking information should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether, or the times at or by which, such future performance will be achieved. Forward-looking information is based on information available at the time and/or the Company management's good faith belief with respect to future events and is subject to known or unknown risks, uncertainties, assumptions and other unpredictable factors, many of which are beyond the Company's control. In particular, the CD Exchange remains subject to TSX Venture Exchange approval, for which the Issuer expects certain discretionary waivers to be required. In the event that such waivers are not obtained, or the TSX Venture Exchange otherwise requires variations to the terms of the CD Exchange, some if not all of the holders of the Old Debentures may withdraw their participation in the CD Exchange. For additional information with respect to other factors and assumptions underlying the forward-looking information made in this news release, see the Company's most recent Management's Discussion and Analysis and financial statements and other documents filed by the Company with the Canadian securities commissions and the discussion of risk factors set out therein. Such documents are available at www.sedarplus.ca under the Company's profile and on the Company's website, www.ReGenIII.com. Readers are cautioned not to unduly rely on forward-looking information. The forward-looking information set forth herein reflects the Company's expectations as at the date of this news release and is subject to change after such date. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.

Not for distribution to United States newswire services or for dissemination in the United States

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/274903

Q2: 2025-11-12 Earnings SummaryEPS of $1.40 beats by $1.05

 |

Revenue of

$669.19M

beats by $27.04M

McGraw Hill, Inc. (MH) Q2 2026 Earnings Call November 12, 2025 8:30 AM EST

Company Participants

Danielle Kloeblen - Senior Vice President of Finance & Investor Relations
Simon Allen - CEO, President & Chairman
Robert Sallmann - Executive VP & CFO

Conference Call Participants

Ryan MacDonald - Needham & Company, LLC, Research Division
Henry Hayden - Rothschild & Co Redburn, Research Division
Stephen Sheldon - William Blair & Company L.L.C., Research Division
Steven Koenig - Macquarie Research
Keen Fai Tong - Goldman Sachs Group, Inc., Research Division
Marvin Fong - BTIG, LLC, Research Division
Toni Kaplan - Morgan Stanley, Research Division
Jeffrey Meuler - Robert W. Baird & Co. Incorporated, Research Division
Faiza Alwy - Deutsche Bank AG, Research Division
Jeffrey Silber - BMO Capital Markets Equity Research
Joshua Chan - UBS Investment Bank, Research Division
David Karnovsky - JPMorgan Chase & Co, Research Division

Presentation

Operator

Good morning, and welcome to the McGraw Hill, Inc., Fiscal Second Quarter 2026 Earnings Conference Call for the Quarter ended September 30, 2025. [Operator Instructions] As a reminder, today's call is being recorded, and a written transcript will be made available in the Events and Presentations section of the company's Investor Relations website. A webcast replay of today's call will also be made available on the company's Investor Relations website. Following the prepared remarks, we will open the call for questions.

I would now like to turn the call over to your host, Danielle Kloeblen, Treasurer and Senior Vice President, Investor Relations. Please go ahead, Danielle.

Danielle Kloeblen
Senior Vice President of Finance & Investor Relations

Good morning, everyone. Welcome to McGraw-Hill's Fiscal Second Quarter 2026 Results. Joining me today are Simon Allen, Chairman, President and Chief Executive Officer; and Bob Sallmann, Executive Vice President and Chief Financial Officer.

During this call, we will be making forward-looking statements about the company. These statements are based on

Recommended For You

NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Molina Healthcare, Inc. (NYSE: MOH) between February 5, 2025 and July 23, 2025, both dates inclusive (the “Class Period”), of the important December 2, 2025 lead plaintiff deadline.

SO WHAT: If you purchased Molina securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Molina class action, go to https://rosenlegal.com/submit-form/?case_id=45913 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than December 2, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period failed to disclose to investors: (1) material, adverse facts concerning Molina’s “medical cost trend assumptions;” (2) that Molina was experiencing a “dislocation between premium rates and medical cost trend;” (3) that Molina’s near term growth was dependent on a lack of “utilization of behavioral health, pharmacy, and inpatient and outpatient services;” (4) as a result of the foregoing, Molina’s financial guidance for fiscal year 2025 was substantially likely to be cut; and (5) as a result of the foregoing, defendants’ positive statements about Molina’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Molina class action, go to https://rosenlegal.com/submit-form/?case_id=45913 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com

In the midst of the current financial market turbulence, Michael Saylor, Executive Chairman of MicroStrategy, maintains his bullish stance on Bitcoin. Despite a significant drop in the cryptocurrency's value, he advises investors to adopt a long-term perspective, specifically a four-year horizon, to successfully navigate the inherent volatility of the market.

In an unexpected turn, Ethereum's network has experienced unprecedented demand for block space, reaching an all-time high. This surge comes as the crypto market undergoes a substantial reset, leading analysts to question whether Ethereum (ETH) is on the brink of its next significant cycle.

Companies

Sharps Technology Posts Debut Quarterly Results, Shares Hit Record Lows

TL;DR Sharps Technology fell to a record low following its first quarterly report with a treasury focused on nearly 2 million Solana tokens. Its medical

Companies

Binance Pay Sees Explosive Growth, Stablecoins Drive Adoption

TL;DR Binance Pay surpassed 20 million merchants in less than a year, showing that cryptocurrency payments are increasingly becoming part of everyday commerce. Over 98%

Markets

Arthur Hayes Offloads $7M in Tokens Amid Market Turmoil

TL;DR Arthur Hayes sold more than $7.42 million in just two days, fueling a scenario defined by accelerated selling, extreme fear and doubts about the

Ethereum News

Ethereum Market Sees Whale Activity: Hayes and 2014 ICO Wallets Reactivate

TL;DR Ethereum is experiencing renewed whale activity as high-profile trader Arthur Hayes and a 2014 ICO-era wallet become active. Hayes rotated 1,480 ETH ($4.7 million)

CryptoCurrency News

Security Alert: Hundreds of Wallets Targeted in x402 Token Exploits, Says GoPlus

TL;DR The x402 token ecosystem is expanding at a pace that outstrips current auditing capacity, leaving numerous vulnerabilities exposed. A GoPlus report identifies a set

Ripple News

XRP Price Projected to Surge 21% as Franklin Templeton Joins ETF Wave

TL;DR XRP is currently trading at $2.16 with a market capitalization of $130.38 billion, showing a 0.06% gain in the last 24 hours. Major financial

In brief
Grayscale's Dogecoin ETF is a conversion from an existing fund.
Activity in the altcoin ETF market has accelerated in recent weeks.
A Bitwise Solana ETF has accumulated assets every day since its debut last month.
A Grayscale exchange-traded fund tracking the popular Dogecoin (DOGE) meme coin could begin trading next Monday, potentially adding to a growing list of U.S.-listed altcoin-focused products available to investors.

The Grayscale Dogecoin Trust (DOGE), a conversion from an existing fund, would trade on the the New York Stock Exchange. Grayscale amended its S-1 prospectus earlier this month, triggering a countdown to its beginning, although NYSE must still file a notice for the listing.

"We'll see, won't be 100% ['til] exchange notice, but based on SEC guidance, it looks good," Bloomberg Senior ETF Analyst Eric Balchunas wrote in an X post Monday

Grayscale's ETF would augment a recent small flurry of activity in the altcoin ETF market. Bitwise's Dogecoin-tracking ETF could also start trading later this month, based on the timing of an SEC filing in early November.

On Monday, fund giant VanEck debuted its Solana ETF (VSOL), which follows the price of the sixth-largest cryptocurrency by market value.

VSOL follows the listing of Canary Capital’s spot XRP ETF (XRPC), which opened last week with $58 million in first-day trading volume, the strongest debut of any ETF this year. That fund's launch followed the roaring start of the Bitwise Solana Staking ETF (BSOL), which racked up $57 million on its first day in late October, according to Bloomberg data, and already manages more than $550 million in assets.

The Rex-Osprey DOGE ETF (DOJE) landed in the top five for trading volumes when it hit the market in September, and the issuers have already applied for a riskier, leveraged version of the fund. DOJE and a Rex-Osprey XRP fund (which also started strongly) offer investors exposure to the two altcoins via a subsidiary registered in the Cayman Islands that is wholly owned and controlled by the fund.

"We will continue to see new ETF products enter the market," Ric Edelman, founder of the Digital Assets Council of Financial Professionals, told Decrypt. "It won’t be a surge, but a steady pace as the marketplace increases its interest in and acceptance of crypto as a legitimate asset class worth of inclusion in diversified portfolios."

The promising ETF starts have come even as crypto markets and investor confidence have sagged. Bitcoin recently fell below $92,000, its lowest level since late April, according to data provider CoinGecko. The largest crypto by market value is off more than 13% over the last week. Solana is down more than 22% for the same period, while XRP and DOGE have dropped about 16% each.

In a Myriad prediction market, 64% of respondents expect Bitcoin's next move will be dropping to $85,000 rather than rising to $115,000, a reversal of trendlines from last week that reflects the growing pessimism about crypto markets. Myriad is a unit of Dastan, the parent company of an editorially independent Decrypt.

But the appetite for funds based on individual altcoins, combinations of tokens and strategies. has remained strong. The SEC is currently weighing about 90 digital asset applications from the crypto and traditional finance worlds.

These companies have been looking to address investor interest in these products following the dramatic success of spot Bitcoin and Ethereum ETFs that began trading last year and now oversee $134 million and $19 million in investments.

Edelman doesn't believe that the recent crypto market downturn will impact the appetite for ETFs.

"If anything, they will accelerate their launches, because launching when prices are low makes the funds’ performances look better once prices rise," he explained.

Daily Debrief NewsletterStart every day with the top news stories right now, plus original features, a podcast, videos and more.

Binance Coin (BNB) has experienced a significant decline, sinking to around $900 from its mid-October high of approximately $1,370. This steep drop has stirred debate among traders and analysts, who are now assessing if this presents a buying opportunity or signals further potential losses.

Undead Games could attempt an all-time high if buyers reclaim momentum and flip critical resistance levels, with $2.59 remaining the key focus.Memecore shows bullish signals from the Ichimoku Cloud, requiring stronger participation to break resistance and retest its previous high near three dollars.BNB stays relatively strong despite market weakness, with rising inflows signaling potential recovery if resistance near one thousand successfully becomes meaningful support.The effect of Bitcoin sliding on the daily chart, hitting $95,000 over the last 24 hours, is visible on the altcoins as well. While some tokens have declined sharply, others have managed to counter the bearish effect to some extent.

BeInCrypto has analysed three altcoins that could hit a new all-time high if the market conditions improve in the coming week.

Sponsored

Sponsored

Undead Games (UDS)UDS is trading at $2.13 and remains below the $2.17 resistance level. The token sits 36% away from its all-time high of $2.90, signaling room for a potential rally if buyers regain control and push momentum back into bullish territory.

For UDS to move higher, it must flip $2.29 into support. A successful breakout could drive the price toward $2.48 and beyond. Clearing the $2.59 resistance would strengthen bullish sentiment and set the stage for a broader upside move.

Want more token insights like this? Sign up for Editor Harsh Notariya’s Daily Crypto Newsletter here.

UDS Price Analysis. Source: TradingViewIf conditions weaken, UDS may fail to hold current levels. A decline to $2.00 or even $1.90 would invalidate the bullish setup and indicate fading investor confidence. This would expose the meme coin to deeper losses.

Sponsored

Sponsored

Memecore (M)M trades at $2.15 and continues to hold above the $2.12 support level. The token remains 39% below its all-time high of $2.99. This highlights the need for stronger investor participation to drive momentum and support a sustained recovery.

The Ichimoku Cloud signals a bullish trajectory for Memecore. Breaking above $2.26 and converting $2.50 into support could lift the price to $2.71. A successful move beyond that level would position M to retest the $2.99 all-time high.

M Price Analysis. Source: TradingViewHowever, this outlook depends on improved market conditions or the start of an altcoin season. Without broader support, M could lose the $2.12 level and slide toward $1.88. This would invalidate the bullish thesis and signal renewed downward pressure.

BNBBNB remains one of the few major altcoins still within visible range of its all-time high, despite trading 47% below the $1,375 peak. Its relative strength highlights continued investor interest, even as broader market conditions remain uncertain.

BNB is seeing a rise in inflows as the Chaikin Money Flow crosses above the zero line. This shift suggests growing confidence, which could help the token break past the $1,000 resistance. A successful move would invalidate the month-long downtrend and open the path toward $1,136.

BNB Price Analysis. Source: TradingViewIf BNB fails to build upward momentum, it risks remaining trapped in the downtrend. A decline below the $902 support may trigger further losses, potentially pushing the price toward $854 or lower. Such a move would invalidate the bullish outlook and signal renewed selling pressure.

Disclaimer

In line with the Trust Project guidelines, this price analysis article is for informational purposes only and should not be considered financial or investment advice. BeInCrypto is committed to accurate, unbiased reporting, but market conditions are subject to change without notice. Always conduct your own research and consult with a professional before making any financial decisions. Please note that our Terms and Conditions, Privacy Policy, and Disclaimers have been updated.

Dogecoin has spent the past few days struggling to regain momentum after a series of pullbacks dragged the price back toward the mid-$0.16 region. The broader market has also been unstable, adding pressure to Dogecoin.

Despite this stretch of bearish price action, a deeper look at the higher-timeframe chart shows a structure that has not been invalidated by the recent decline. This is where a technical analysis from XForceGlobal comes in, as he argues that Dogecoin is sitting inside an “insanely bullish” long-term formation that is unfolding beneath the surface.

The 5-Wave Structure Behind Dogecoin’s Bullish Setup
A detailed technical analysis shared by XForceGlobal on the social media platform X argues that Dogecoin is nearing the final stages of an Elliott Wave formation. His interpretation points to cycle targets well above $1 and frames the ongoing price action as part of a developing fifth impulse wave.

The chart shared by XForceGlobal outlines an idealized Elliott Wave cycle that stretches back almost a decade. Dogecoin has already completed the first four major waves on the macro level.

The technical analysis shows the fifth wave technically began months ago, with the fourth wave bottom forming sometime between late 2023 and early 2024. However, the prolonged pullbacks of the past few months introduce the possibility that the fourth wave may still be playing out, instead of the fifth wave.

Source: Chart from XForceGlobal on X
Despite the choppy price action, the analysis shows that the fourth wave low is protected, and the current price action is still the fifth wave.  The chart also shows how Dogecoin has been distributing within a narrowing structure, but the lows have consistently held. 

Both of the scenarios visualized on Dogecoin’s price chart still lead to a new all-time high once the rally resumes for another strong push.

Why The Next Dogecoin Wave Points Toward $1
XForceGlobal noted that “cycle targets are still $1+,” a projection supported by the geometry of the fifth wave. The structure resembles the same formations that highlighted Dogecoin’s massive expansions in earlier bull cycles, particularly in 2017 and 2021. Nonetheless, it’s important to note that there’s still room for more distribution.

The current resistance zones sit far below his projected fifth-wave target zone, and the broader market structure shows no violation of the wave-4 levels that must hold for the setup to still be valid. 

The chart highlights a potential path that first moves through the $0.33-$0.47 zone before clearing the psychological $0.50 threshold and finally breaking above its current all-time highs at $0.731 and further up into the $1 region. 

A full extension of the fifth wave from present levels implies a price target around $1.768. At the time of writing, Dogecoin is trading at $0.1618.

DOGE trading at $0.16 on the 1D chart | Source: DOGEUSDT on Tradingview.com
Featured image from Peakpx, chart from Tradingview.com

flash news

Binance Introduces New USDC Spot Listings Alongside Trading Bot Features

Binance will roll out a synchronized update to its spot marketplace and automated trading tools on November 18, introducing new USDC-based pairs and features.

Companies

Sharps Technology Posts Debut Quarterly Results, Shares Hit Record Lows

TL;DR Sharps Technology fell to a record low following its first quarterly report with a treasury focused on nearly 2 million Solana tokens. Its medical

Companies

Binance Pay Sees Explosive Growth, Stablecoins Drive Adoption

TL;DR Binance Pay surpassed 20 million merchants in less than a year, showing that cryptocurrency payments are increasingly becoming part of everyday commerce. Over 98%

Markets

Arthur Hayes Offloads $7M in Tokens Amid Market Turmoil

TL;DR Arthur Hayes sold more than $7.42 million in just two days, fueling a scenario defined by accelerated selling, extreme fear and doubts about the

Ethereum News

Ethereum Market Sees Whale Activity: Hayes and 2014 ICO Wallets Reactivate

TL;DR Ethereum is experiencing renewed whale activity as high-profile trader Arthur Hayes and a 2014 ICO-era wallet become active. Hayes rotated 1,480 ETH ($4.7 million)

CryptoCurrency News

Security Alert: Hundreds of Wallets Targeted in x402 Token Exploits, Says GoPlus

TL;DR The x402 token ecosystem is expanding at a pace that outstrips current auditing capacity, leaving numerous vulnerabilities exposed. A GoPlus report identifies a set

TL;DR:

ZEC rises 28% in two weeks, prompting scrutiny from market strategist James Wynn.
Trading volume has doubled, but rapid gains and overbought RSI suggest potential corrections.
Wynn advises disciplined trading with stop-losses and partial profit-taking to manage risk.

Zcash (ZEC) has captured market attention following a parabolic price surge, drawing both investor excitement and caution. The cryptocurrency climbed more than 28% in the past two weeks, reversing earlier declines and prompting analysts to review its trajectory. James Wynn, a noted market strategist, issued warnings to traders about potential overextension and heightened volatility, highlighting that rapid gains often precede pullbacks. Market participants are monitoring liquidity and trading volume, which have surged alongside the price, signaling active speculation.

🇺🇸 Fidelity predicts that one #Zcash $ZEC will be worth $100,000 by 2028 pic.twitter.com/YPzQ0J22wH

— Crypto Guru (@BDCryptoGuru) November 16, 2025

Analyst Wynn Flags Potential Risks Amid ZEC Rally
Wynn emphasized that ZEC’s rapid appreciation might trigger short-term corrections, citing historical patterns where parabolic moves have been unsustainable. The strategist noted that despite bullish momentum, ZEC is trading at levels above key support zones, increasing the likelihood of profit-taking. Traders are encouraged to assess their exposure carefully, with risk management strategies including stop-loss orders and partial profit realization being recommended to mitigate sudden drops.

Market data indicates that ZEC’s trading volume has doubled compared to the previous month, reflecting heightened investor interest. Exchanges report increased order book activity, particularly from retail traders chasing momentum. While some see this as a sign of strong market confidence, Wynn warns that excessive leverage could amplify potential losses, making disciplined trading crucial. Investors are also watching ZEC’s correlation with broader cryptocurrency trends, as its performance increasingly mirrors BTC’s movements in high-volatility periods.

Further scrutiny comes from ZEC’s technical indicators, showing RSI levels entering overbought territory, which traditionally signals a slowdown in upward momentum. Market participants are evaluating whether the surge represents a genuine breakout or a speculative spike. As regulators and analysts monitor the ecosystem, traders are urged to remain vigilant, balancing optimism with caution to avoid significant drawdowns. The combination of high volume, rapid gains, and overbought conditions highlights the delicate balance between opportunity and risk in the current ZEC rally.

Kohaku is a suite of privacy-preserving crypto tools to enhance privacy and security in the Ethereum ecosystem.

Binance Coin extended its weekly decline on November 17, dropping after a pullback in the last 24 hours, according to market data. The cryptocurrency traded firmly below a key psychological level, reflecting broader market stress across large-cap digital assets.

The dip comes amid growing scrutiny of Binance, especially after its founder, Changpeng Zhao, received a controversial pardon from President Trump, raising questions about potential pay-to-play allegations.

Summary

Binance Coin extended its weekly decline on November 17, trading below a key psychological level as market stress impacted large-cap digital assets.
A jump in 24-hour trading volume amid falling market cap indicated intensified selling pressure, while technical analysis showed a persistent downtrend with lower highs and lows.
RSI indicators showed weakening bullish momentum, signaling potential continued bearish sentiment unless a price rebound occurs above a key resistance level.

Binance technicals
The token’s market capitalization fell while 24-hour trading volume jumped significantly, indicating intensified selling pressure, according to trading data.

The chart below shows a loss of momentum throughout the last few weeks, with a sequence of lower highs and lower lows confirming a persistent downtrend.

At last check, BNB was down 18% for the month, trading at roughly $903.

Courtesy of CoinGecko
Price action repeatedly failed to reclaim a previously important zone, which has now flipped into resistance, according to the chart data. The sharp late-session drop brought Binance Coin to its lowest point since early November.

The Relative Strength Index (RSI) signaled weakening bullish momentum but had not yet reached oversold territory, according to technical indicators. Throughout the week, the RSI repeatedly failed to break above mid-range levels, indicating that buyers have been unable to regain control. The most recent RSI dip showed temporary capitulation before a minor recovery, but momentum remained bearish.

More bad news for Binance
Binance has been linked to the flow of at least $28 billion tied to illicit activity in the cryptocurrency space over the past two years, as revealed by an investigation from the International Consortium of Investigative Journalists and other global media outlets.

This “dirty money,” according to the New York Times, is from hackers, thieves, and scammers. It’s funneled into, not just Binance, but other prominent exchanges like OKX.

The report highlights how criminal organizations, including North Korean cybercriminals, have used crypto exchanges to launder funds. Despite this, Binance, the world’s largest exchange, continues to grow.

In May, Binance inked a $2 billion deal with an Emirati fund using digital currency from the Trump family’s World Liberty Financial firm. Around that time, Zhao (known in the industry as CZ) applied for a pardon.

Zhao had served a four-month term in prison. Trump subsequently pardoned Zhao, sparking scrutiny and raising concerns about potential corruption allegations.

Trump later denied even knowing who Zhao was.

In brief
KindlyMD's stock fell nearly 10% Monday after missing its Q3 earnings deadline, citing complex accounting from its Nakamoto merger.
The Bitcoin treasury firm's shares are down 95% from six months ago.
Expected Q3 results include a $59 million loss on the Nakamoto acquisition, $22 million in unrealized digital asset losses, and $1.4 million in realized losses from selling crypto.
Bitcoin treasury company Kindly MD’s share price dropped nearly 10% Monday after the firm said Friday that it won’t be able to meet the deadline for its third-quarter earnings “without unreasonable effort or expense.”

The company’s shares, which trade on the Nasdaq under the NAKA ticker, had fallen to $0.55 by the end of the trading day. NAKA is now 25% down from a week ago, and more than 95% lower than it was six months ago.

Large companies file within 40 days after the end of a quarter. All other U.S. publicly traded companies, including KindlyMD, have 45 days to file after the end of a quarter. For Q3, which ended on Sept. 30, that cutoff was November 14.

But instead of its 10-Q, KindlyMD filed paperwork with the U.S. Securites and Exchange Commission on Friday to say the complexity of accounting related to its merger with Nakamoto has “necessitated additional time to ensure the accuracy and completeness of the information.”

KindlyMD merged earlier this year with Nakamoto, a Bitcoin treasury firm formerly known as Nakamoto Games. As part of the merger, Nakamoto founder David Bailey was named CEO in August.

Bailey has remarked on X about a new CEO taking over at BTC Inc., which he co-founded, but has not directly commented on the company’s share price or late quarterly earnings.

The firm did signal in its filing that its numbers will show a “significant change” compared to this time last year.

NAKA said it expects to report a realized loss of $1.4 million on digital assets, meaning that it sold some of them. There will also be an unrealized loss of more than $22 million on digital assets it still holds, and a $14.4 million loss on extinguishment of debt.

The filing also says the company will report a $59 million loss on its acquisition of Nakamoto, meaning that it paid more to acquire the company than the fair value of net assets received.

But the company also said it expects to report a $21.8 million positive change in the fair value of contingent liability. That means one of the company’s liabilities has been marked down in value, which shows up in earnings as a gain.

Daily Debrief NewsletterStart every day with the top news stories right now, plus original features, a podcast, videos and more.

In brief
Bitcoin erased all 2025 gains, falling below $93,000 for the first time in nearly seven months.
Analysts point to breaking below the 50-week moving average and bearish sentiment around the potentially delayed four-year cycle as key factors in the downturn.
The $92,000 level marks critical support that coincides with an unfilled CME gap, though macro uncertainties and weak liquidity could limit any rebound.
Bitcoin has now erased all of its 2025 gains, dipping below the $93,000 mark on Monday for the first time in nearly seven months.

Bitcoin was recently trading for $92,123 after having dropped 2.3% in the past day and about 13% in the past week, according to crypto price aggregator CoinGecko. Trading volume for BTC has more than doubled in the past day, jumping to $114 billion according to CoinGlass.

So far, about $335 million worth of Bitcoin derivatives contracts have been liquidated in the past day, pushing total crypto market liquidations to $725 million over the last 24 hours.

“The break below the 50-week moving average and a weekly close under $100K for the first time since May 4 have cemented a more cautious tone across digital asset markets,” wrote analysts at QCP Capital, a Singapore-based crypto trading firm. “In a space where narrative often drives price, talk of the four-year cycle nearing its end has only added to the prevailing bearish sentiment.”

The QCP team alluded to the end of the four-year cycle for Bitcoin. Since its inception, Bitcoin has experienced what’s called a halving event roughly every four years. And in the interim, it usually experiences a significant price drawdown about 12- to 18-months after each halving. After the most recent April 2024 halving, BTC neared the end of that window in October.

Leading up to October, many analysts said the four-year cycle had ended. But now, some analysts are saying it’s not quite over—just delayed.

The QCP analysts flagged $92,000 as a key support level for BTC, adding that that price served as a lower bound late last year and early this year. As of this writing, Bitcoin is now very close to breaking that barrier.

“The 92K region also coincides with an unfilled CME gap, increasing the odds of a short-term technical bounce if tested. Yet, as seen over the past few weeks, dense overhead supply could limit the strength of any rebound,” the analysts wrote. “Add to that the rising macro uncertainties and a sluggish return of liquidity to crypto markets, and the picture remains fragile even with the U.S. government now officially reopened.”

The CME gap that the QCP analysts mentioned refers to a difference in the spot price for Bitcoin—which never stops trading—and the price when the closing bell rang for CME Bitcoin derivatives contracts on Friday afternoon.

The U.S. government shutdown ended last week, becoming the new longest shutdown on record after dragging on for 43 days. But the macroeconomic picture still hasn’t clarified enough to restore investor confidence.

Users on Myriad, a prediction market owned by Decrypt’s parent company Dastan, are now overwhelmingly certain that BTC will dip as low as $85,000 sooner than it can climb to $115,000 again. Users now think there’s a 63% chance that BTC will dive to $85K, a jump of 30% in the past day.

Daily Debrief NewsletterStart every day with the top news stories right now, plus original features, a podcast, videos and more.

After years in the wilderness, Zcash (ZEC) has staged a roughly 740% price “pump” this year, with analysts linking the move to surging demand for on-chain privacy and a cluster of high-profile endorsements. The speed and timing of the rally have ignited a heated debate on X: is Zcash’s resurgence driven by coordinated paid promotion, or by genuine improvements in its technology and monetary design?

The flashpoint came from infrastructure founder Mert Mumtaz (@0xMert_), who mocked the idea that a single “mega-whale” is paying off every visible supporter. “There’s a person in crypto so rich that they are simultaneously paying off Cobie, Naval Ravikant, Balaji Srinivasan, me, Tim Ferris, [Arthur] Hayes, Gainzy, path, Ansem, the Winklevoss Twins, Toly [Yakovenko] and more. (all of whom require just one final OTC KOL deal to finally make it). Either that or I’m retarded.”

there’s a person in crypto so rich that they are simultaneously paying off cobie, naval, balaji, me, tim ferris, hayes, gainzy, path, ansem, the winklevoss twins, toly and more

(all of whom require just one final OTC KOL deal to finally make it)

either that or I’m retarded

— mert | helius.dev (@0xMert_) November 16, 2025

In a follow-up, he argued the real story is investor psychology, writing that “people would rather believe the above than admit that they sidelined themselves due to poor thinking and emotion.”

Why Is Zcash Surging Now?
Mert then laid out why, in his view, Zcash is rallying now: a more favorable political window for privacy coins in the US, issuance reduction, NEAR Intents that turn ZEC into a “shielded swiss vault” for one-click cross-chain payments, the default-shielding Zashi wallet with “100x better UX,” the 100x-scaling ambitions of Project Tachyon.

On the long list of arguments he added the disillusionment with an increasingly institutional Bitcoin, Europe’s tightening surveillance regime, maturing zero-knowledge tech, fatigue with supply-controlled coins that were “dumped” on retail, and the broader “debasement trade” pushing investors toward alternative stores of value. He closed: “you combine all of the above with a little spark and the fire spreads fast. There is no conspiracy, just think. This is not a trade.”

Skeptics see the same facts very differently. One user complained that Jordan Fish [@Cobie), a prominent UK-based crypto investor and trader, had become a “paid zcash shill,” and asked whether “all the big KOLs just randomly decided to just start shilling Zcash.”

Cobie replied that his interest was not new at all: “Just started? I have been doing this almost 10 years (painfully),” resurfacing a 2017 tweet about buying ZEC if the price ever hit $0.3. When his critic apologized, Cobie turned to fundamentals: “Zcash has a lot of recent developments actually IMO. (1) One of the coolest things I have seen: Project Tachyon. (2) They fixed the brutal inflation that killed us. (3) Zcash + NEAR intents for permissionless cross-chain swaps seems to actually be working.”

Zcash has a lot of recent developments actually IMO.

(1) One of the coolest things I have seen: https://t.co/3wXNpugkna

(2) They fixed the brutal inflation that killed us

(3) Zcash + NEAR intents for permissionless cross-chain swaps seems to actually be working:… pic.twitter.com/JgVFh9Xg3T

— Cobie (@cobie) November 16, 2025

Those developments are verifiable. Zcash’s engineering roadmap has advanced from experimental cryptography to production-grade systems. Project Tachyon, outlined by Zcash researcher Sean Bowe, proposes “oblivious synchronization,” a way for wallets to sync shielded notes without leaking metadata, drastically lowering latency and making large-scale shielded usage practical.

On the user side, the Zashi wallet has become the flagship interface, abstracting away complex shielding flows and steering users into private, shielded transactions by default. Research from Galaxy and other analysts notes that shielded supply has climbed from low single-digit percentages a few years ago to roughly a quarter of all circulating ZEC, with estimates around 30% of supply now parked in the shielded pool.

Influencer activity undeniably amplifies this. Naval Ravikant’s October post, “Bitcoin is insurance against fiat. ZCash is insurance against Bitcoin,” was widely cited as an immediate catalyst for a sharp doubling in ZEC’s price and cemented the “privacy insurance” meme.

The Zcash debate ultimately sits at the intersection of reflexive markets and real progress. Genuine upgrades in issuance, UX and scalability, plus a harsher global climate for financial privacy, have created a strong fundamental backdrop.

Vocal advocates with large audiences have compressed years of re-rating into weeks, leaving sidelined traders searching for explanations. Whether one calls that paid promotion, organic momentum or a feedback loop of both, the current cycle shows how quickly a once-written-off privacy coin can become crypto’s latest battleground.

At press time, ZEC traded at $682.

ZEC hovers below the 2.0 Fib extension, 1-week chart | Source: ZECUSDT on TradingView.com
Featured image created with DALL.E, chart from TradingView.com

Key points:

Bitcoin’s fall has resulted in three consecutive weeks of outflows from crypto ETPs, indicating a negative sentiment.

Several altcoins are struggling to start a rebound, indicating a lack of demand from buyers.

Bitcoin (BTC) attempted a recovery to start the week, but the long wick on the candlestick shows selling at higher levels.

Several analysts believe that the market is likely to bottom soon and that the worst is over. Bitwise CEO Hunter Horsley said in a post on X that BTC has been in a bear market for the past six months, which is about to end. He added that the setup for crypto “has never been stronger.”

However, crypto sentiment platform Santiment cautioned in a report that “true bottoms often form when the majority expects prices to fall further” and not when there is a consensus about a “specific price bottom.”

Crypto market data daily view. Source: TradingView Traders should keep a close eye on crypto investment products, which have witnessed three consecutive weeks of outflows totaling $3.2 billion. Last week alone saw $2 billion in outflows, the largest weekly outflows since February, according to a report from CoinShares. Sustained buying into crypto ETPs will be needed for a meaningful recovery.

Could BTC extend its decline, pulling altcoins lower or is a recovery around the corner? Let’s analyze the charts of the top 10 cryptocurrencies to find out. 

S&P 500 Index price predictionThe S&P 500 Index (SPX) has formed a symmetrical triangle pattern, indicating indecision between the bulls and the bears.

SPX daily chart. Source: Cointelegraph/TradingViewIf the price turns down and breaks below the support line, it signals the start of a deeper correction toward 6,550 and then 6,400. The pattern target of the break from the triangle is 6,276.

Alternatively, if the price continues higher and breaks above the resistance line, it indicates the resumption of the uptrend. The index may rally to 7,000 and then to the target objective of 7,220.

US Dollar Index price predictionThe US Dollar Index (DXY) turned down from the 100.50 overhead resistance level on Nov. 5 but is taking support at the 20-day exponential moving average (99.32).

DXY daily chart. Source: Cointelegraph/TradingViewIf the price rebounds off the 20-day EMA with strength, the likelihood of a break above the 100.50 level increases. The index could then climb to the 102 level, where the bears are again expected to mount a strong defense.

Sellers will have to pull the price below the 50-day simple moving average (98.57) to gain the upper hand. If they do that, the index may consolidate between 100.50 and 96.21 for a while longer.

Bitcoin price predictionBTC is attempting to take support at the $93,000 level, but the lack of a solid rebound indicates that the bears continue to exert pressure.

BTC/USDT daily chart. Source: Cointelegraph/TradingViewAny recovery attempt is expected to face selling at the psychological level of $100,000. If the price turns down from $100,000, it suggests that the bears have flipped the level into resistance. That heightens the risk of a drop to $87,800 and subsequently to $83,000.

Time is running out for the bulls. They will have to swiftly drive the Bitcoin price above the 20-day EMA ($102,022) to weaken the bearish momentum. The BTC/USDT pair may then climb to the 50-day SMA ($109,927).

Ether price predictionEther (ETH) has been trading below the breakdown level of $3,350, but the bears have failed to sink the price below $3,000.

ETH/USDT daily chart. Source: Cointelegraph/TradingViewThe ETH/USDT pair could rise to the 20-day EMA ($3,444), where the bears are expected to sell aggressively. If the price turns down sharply from the 20-day EMA, the pair risks a break below $3,000. If that happens, the Ether price may plunge to $2,500.

Contrarily, if buyers kick the price above the 20-day EMA, the pair could rally to the 50-day SMA ($3,871). A close above the 50-day SMA suggests that the corrective phase may be ending.

XRP price predictionXRP (XRP) has been falling inside a descending channel pattern, indicating that the bears continue to sell on rallies.

XRP/USDT daily chart. Source: Cointelegraph/TradingViewThere is minor support at $2.15, but if the level cracks, the XRP/USDT pair could plummet to the support line of the channel. Buyers are expected to aggressively defend the support line, as a break below it may sink the pair to $1.61.

On the upside, a break and close above the 50-day SMA ($2.52) suggests that the bulls are attempting a comeback. A short-term trend change will be signaled after buyers achieve a close above the downtrend line.  

BNB price predictionBNB (BNB) is attempting to stay above the $860 level, but the recovery is expected to face selling at the 20-day EMA ($983).

BNB/USDT daily chart. Source: Cointelegraph/TradingViewIf the price turns down sharply from the 20-day EMA, the bears will again try to sink the BNB/USDT pair below the $860 level. If they manage to do that, the BNB price could collapse to $730.

Contrary to this assumption, if the price turns up and breaks above the 20-day EMA, it suggests that the selling pressure is reducing. The pair may then rise to the 50-day SMA ($1,082). 

Solana price predictionSolana (SOL) has been gradually sliding toward the solid support at $126, indicating that the bears remain in control.

SOL/USDT daily chart. Source: Cointelegraph/TradingViewAny recovery attempt is expected to face selling at the 20-day EMA ($159). If the price turns down sharply from the 20-day EMA, the risk of a break below $126 increases. The Solana price could then dive to $95.

Instead, if the price breaks above the 20-day EMA, it signals solid demand at lower levels. The SOL/USDT pair could then rise to the 50-day SMA ($186), where the bears are expected to step in.

Dogecoin price predictionDogecoin (DOGE) is trying to take support near $0.15, but the bulls are struggling to start a strong recovery.

DOGE/USDT daily chart. Source: Cointelegraph/TradingViewIf the price turns down from the 20-day EMA ($0.17), the likelihood of a drop to $0.14 increases. Buyers are expected to defend the $0.14 level with all their might, as a break below it could sink the Dogecoin price to $0.10.

On the contrary, a break and close above the 20-day EMA suggests that selling dries up near $0.14. The DOGE/USDT pair may then rally to the 50-day SMA ($0.19). Such a move indicates that the pair could extend its stay inside the $0.14 to $0.29 range for some more time.

Cardano price predictionCardano (ADA) dipped below the $0.50 support on Friday, indicating that the bears remain in charge.

ADA/USDT daily chart. Source: Cointelegraph/TradingViewThe bulls are attempting to push the Cardano price back above the breakdown level of $0.50. If they succeed, the ADA/USDT pair could ascend to the 20-day EMA ($0.55). Sellers will try to halt the recovery at the 20-day EMA. If that happens, the bears will try to extend the decline to $0.40.

A minor positive for the bulls is that the RSI is attempting to form a positive divergence. That suggests the selling pressure is reducing. If buyers clear the hurdle at the 20-day EMA, the pair could rally to the 50-day SMA ($0.65).

Hyperliquid price predictionHyperliquid (HYPE) has been trading between the 50-day SMA ($41.78) and the $35.50 support for the past several days.

HYPE/USDT daily chart. Source: Cointelegraph/TradingViewThis tight-range trading is expected to culminate in a range expansion, but it is difficult to predict the direction of the breakout. If the price pierces the 50-day SMA, the HYPE/USDT pair could surge to $52.

Conversely, if the price drops below $35.50, it signals that the bears have overpowered the buyers. That could accelerate selling and sink the Hyperliquid price to $30.50 and subsequently to $28. 

This article does not contain investment advice or recommendations. Every investment and trading move involves risk, and readers should conduct their own research when making a decision.

LTC/USD Daily Chart (Coinbase) – Source: TradingView

Paired with this change in the Fed’s dot plot, we may not get new all-time highs this year for tokens other than BNB Coin (BNB) and Ethereum (ETH).

The Relative Strength Index (RSI) for LTC has dropped below the 14-day moving average, reflecting that negative momentum is accelerating. The 200-day exponential moving average would be the key resistance to watch moving forward.

As long as the price trades below this line, it means that the dominant trend is bearish. If LTC hits $80 again, as it did recently, this would mean a downside risk of 13% in the next few days.

Meanwhile, the market’s lack of appetite for Litecoin’s ETF could be interpreted as a signal that institutional interest is weak, which could have a dramatic impact on the token’s long-term performance.

Other Key Levels to Watch for LTC
Heading to a lower time frame, the price just dropped below a former area of support at $93 that could now act as resistance if LTC tries to recover in the next few days.

Altcoin season has remained distant as the Crypto Fear and Greed Index has hovered near yearly lows and traders have preserved liquidity, while Bitcoin has held near $94K and UNI, ENA, and IMX have shown measured strength tied to protocol usage, yield stabilization, and ongoing gaming development.